Sort
78,016 grants matching “breast cancer”
Intratumor heterogeneity and tumor evolution
$960,545Karl Ried · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)
$960,380Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Asian Community Cancer Health Disparities Center (ACCHDC)
$960,300Grace X Ma · Temple Univ Of The Commonwealth · U54 · FY2012 · CA
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease
$960,291Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Molecular linkages between epigenetic regulation and metabolism in breast cancer
$960,171Kevin Gardner · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
INTEGRATED ULTRASONIC SYSTEMS FOR NONINVASIVE THERAPY
$960,100Riverside Research Institute · R01 · FY2004 · CA
United for Health Equity - Living PDX Program (U4HELPP)
$960,065Jose G. Trevino · Virginia Commonwealth University · U54 · FY2024 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$960,045Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
TARGETED INHIBITION OF LEUKEMIA INHIBITORY FACTOR (LIF)/LIFR AXIS FOR THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
$960,000Evestra, Inc. · · FY2018 · Department of the Army
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2020 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2016 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2018 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2017 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,994Filippo G Giancotti · Columbia University Health Sciences · R35 · FY2021 · CA
The Antigen Targeting Core
$959,871Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Mastectomy Reconstruction Outcome Consortium (MROC Study)
$959,795Edwin G. Wilkins · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
CCOP: Colorado Cancer Research Program
$959,745Eduardo R Pajon · Western States Cancer Research Ncorp · U10 · FY2010 · CA
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)
$959,375H-H. Sherry Chow · University Of Arizona · UG1 · FY2019 · CA
Breast & prostate cancer & hormone-related gene variants
$959,127Elio Riboli · Imperial College Of Science, Technology And Medicine · U01 · FY2006 · CA
LncRNA mechanisms in cancer
$958,723Howard Y Chang · Stanford University · R35 · FY2020 · CA
CLINICAL UTILITY OF MICROFLUIDIC ASSAY FOR PROGNOSIS AND PRECISION MEDICINE IN BREAST CANCER
$958,563University Of Maryland, Baltimore · · FY2022 · Defense Health Agency
Chemoprevention and therapeutic treatment of BRCA1 associated mammary tumors
$958,473Chuxia Deng · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors
$958,225D. Martin Watterson · Northwestern University At Chicago · U01 · FY2012 · AG
Developmental Core- Pilot Projects, Full Projects, Biostat Core and Outreach Prog
$958,039Raymond Nelson Dubois · University Of Tx Md Anderson Can Ctr · U54 · FY2012 · CA
Using Community Health Navigators to Advance Cancer Screening Adherence through Videoconferencing for all Americans who use ASL: A Randomized Controlled Trial Study
$957,649Poorna Kushalnagar · Gallaudet University · U01 · FY2025 · DC